Biocept
BIOC
$0.43
Share price
0.00%
Change (1 day)
-95.74%
Change (1 year)
Categories
Biocept (BIOC) - Total debt
Total debt on the balance sheet as of June 2023 : $11.59 M
According to Biocept 's latest financial reports the company's total debt is $11.59 M. A company’s total debt is the sum of all current and non-current debts.
Biocept - Total debt on balance sheet (from 2012 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $12.1 M | -4.45% |
| 2021-12-31 | $12.67 M | 3.63% |
| 2020-12-31 | $12.22 M | 381.45% |
| 2019-12-31 | $2.53 M | 56.16% |
| 2018-12-31 | $1.62 M | -40.37% |
| 2017-12-31 | $2.72 M | -17.84% |
| 2016-12-31 | $3.32 M | -28.27% |
| 2015-12-31 | $4.62 M | -5.13% |
| 2014-12-31 | $4.87 M | -32.06% |
| 2013-12-31 | $7.18 M | -67.91% |
| 2012-12-31 | $22.37 M | 64.35% |
| 2011-12-31 | $13.61 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Veracyte VCYT | $12.63 M | 8.96% | 🇺🇸 USA |
 Exact Sciences EXAS | $2.55 B | 21,940.63% | 🇺🇸 USA |
 Myriad Genetics MYGN | $0.15 B | 1,212.23% | 🇺🇸 USA |